Free Nursing CE 2017‑2018 | CMEList.com

 


Obesity: Expert Management Perspectives and Updates from Obesity Week
Live online November 11, 2016, and available on demand through May 11, 2017.
Posted by...Bernard Sklar, MD.Free Obesity CME
Free Obesity CME Credit hours...1.0. 
CME Credits Awarded by....Boston University School of Medicine..
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for primary care physicians, gastroenterologists, surgeons, pharmacists, nurses, nurse practitioners and other clinicians involved in the treatment and management of obesity.
Educational material updated... November 11, 2016.
Expiration of CME credit...May 11, 2017.
Financial Support...None
After viewing Obesity: Expert Management Perspectives, you will be better able to:
• Apply the approach that obesity is a disease, not a behavioral problem, and in that context more identify more effective collaborative methods to overcome patient barriers to following an optimized weight management plan
• Identify the indications for each of the spectrum of obesity treatments, including lifestyle interventions, pharmacotherapy, and surgery for individualized obesity management
• Describe the pharmacology of the currently available medications for obesity, their indications and adverse effect profile, and how to initiate and titrate them as part of an effective obesity treatment program
• Describe key clinical reports from Obesity Week 2016

Basal Insulin as a Foundation of Diabetes Treatments: Innovative Approaches Free Diabetes CME
Live online February 1, 2017and April 5, 2017  and available on demand through October 5, 2017.
Posted by...Bernard Sklar, MD.
Free Diabetes CME Credit hours...2.0. (1,0 hour for each)
CME Credits Awarded by....Primary Care Network.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for endocrinologists, primary care clinicians, physician assistants, nurse practitioners, pharmacists, certified diabetes educators and other health care providers who provide frontline glycemic management for type 2 diabetes and related conditions.
Educational material updated....April 5, 2017.
Expiration of CME credit...October 5, 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.
After viewing the two presentations of Basal Insulin as a Foundation of Diabetes Treatments,  you will be better able to:
• Describe the pharmacokinetics and pharmacodynamics of the newer ultra-long basal and follow-on biologic ("biosimilar") insulin formulations and how these differ from older formulations
• Determine indications and methods to transition from analog basal insulin to ultra-long basal insulins and follow-on biologic ("biosimilar") basal insulins to help achieve individualized patient treatment goals
• Examine the evidence-based, guideline-driven protocols for therapeutic advancement to basal insulin therapy alone or in combination with other treatment modalities to achieve individualized patient goals
• Identify potential patient, provider, and health care system barriers to initiation and titration of established and newer basal insulins, and methods to overcome these barriers

The Best of Stroke Forum 2016  Free Stroke CME
Posted by...Bernard Sklar, MD. 
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Emergency medicine physicians, neurologists, emergency medicine residents, nurses, physician assistants, nurse practitioners, and other health care professionals involved in the treatment of patients with AIS.
Educational material last updated...November 10, 2016.
CME Credit Expires...November 9, 2017.
Financial Support...Genentech, Inc.
The Best of Stroke Forum 2016 consists of two brief lectures:
• Eligibility for IV Thrombolysis: A Review of Inclusion and Exclusion Criteria
• Stroke Therapy: Examining New Evidence
After competing The Best of Stroke Forum 2016, you should be better able to:
• Apply evidence-based criteria to the selection of candidates for thrombolytic therapy in AIS.
• Evaluate FDA labeling, current data, and clinical practice guidelines on the use of tissue plasminogen activator in the extended 3-hour to 4.5-hour post-onset window.
• Assess recent studies and guidelines on endovascular procedures for AIS.
• Determine the criteria for the concomitant or preferential use of tissue plasminogen activator in patients with AIS who are being considered for endovascular procedures.
• Incorporate shared decision making with patients and their families to improve education and assist in reducing delays in treatment and complications.

An Update on Fixed-Dose LAMA/LABA Inhalers in COPD
Posted by...Bernard Sklar, MD. Free Lung Cancer CME
Free Pulmonology CME Credit hours...2.0.
CME Credits Awarded by....The France Foundation
Cost...........Free.
Instruction Type...Text-and-Graphics.
Target Audiences...This program is intended for health care professionals who treat and manage patients with COPD.
Educational material updated....September 30, 2016.
Expiration of CME credit...September 29, 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc.
An Update on Fixed-Dose LAMA/LABA Inhalers in COPD consists of written presentations by 4 experts on the use of Fixed-Dose Inhalers in COPD
Upon completion of An Update on Fixed-Dose LAMA/LABA Inhalers in COPD, you should be able to:
• Evaluate key efficacy data from clinical trials on new and emerging fixed-dose LAMA/LABA inhalers in COPD.
• Evaluate key safety data from clinical trials on new and emerging fixed-dose LAMA/LABA inhalers in COPD.
• Apply information on the efficacy and safety of new/emerging LAMA/LABA inhalers in COPD to specific clinical scenarios.

Improving Bone Strength and Reducing Fracture Risk in Osteoporosis
Posted by...Bernard Sklar, MD. Osteoporosis CME
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Endocrinologists, internal medicine physicians, and other health care professionals involved in the treatment of patients with osteoporosis.
Educational material last updated...September 1, 2016.
CME Credit Expires...August 31, 2017.
Financial Support...Merck & Co., Inc.
Improving Bone Strength and Reducing Fracture Risk in Osteoporosis consists of two brief video lectures on the causes and treatments of osteoporosis.
Upon successful completion of Improving Bone Strength and Reducing Fracture Risk in Osteoporosis, you should be better able to:
• Outline the mechanisms of action of currently available and emerging resorption inhibitors, anabolic agents, and other therapeutic options for osteoporosis.
• Assess screening and diagnostic modalities that allow for the prompt management of osteoporosis.

How Low Can You Go? LDL - Is Lower Really Better?
Posted by...Bernard Sklar, MD. cholesterol CME
Free CME Credit Hours...1.0.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Cardiologists, endocrinologists, primary care physicians, family physicians, internists, and other health care professionals involved in the treatment of patients with dyslipidemia.
Educational material last updated...August 25, 2016.
CME Credit Expires...August 24, 2017.
Financial Support...Amgen.
How Low Can You Go? LDL - Is Lower Really Better?  features interviews with clinical experts, who discuss newly released evidence and guidelines regarding cardiovascular risk assessment, best practices when evaluating patients with elevated LDL-C, clinical study data pertaining to the effects of lowering LDL-C beyond evidence-based recommendations, and use of non-statin therapies for the treatment of dyslipidemia in patients who cannot achieve desired target levels.
Upon successful completion of How Low Can You Go? LDL - Is Lower Really Better?, you should be better able to:
• Incorporate cardiovascular risk assessment, evidence-based guidelines, and best practices when evaluating patients with elevated LDL-C.
• Assess clinical study data pertaining to the effect of lowering LDL-C beyond evidence-based recommendations and its effect on cardiovascular risk reduction.
• Evaluate the use of non-statin therapies for the treatment of dyslipidemia in patients who are intolerant or in patients who cannot achieve desired target levels. • Incorporate therapeutic regimens with demonstrated ability to reduce risk markers other than LDL-C.
• Incorporate therapeutic regimens with demonstrated ability to reduce risk markers other than LDL-C.

Lung Immunotherapies: Shifting the Lung Cancer Treatment Paradigm
Live online November 3, 2016, and available on demand through May 3, 2017.
Posted by...Bernard Sklar, MD.Lung Cancer CME
Free Oncology CME Credit hours...1.0. 
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for medical oncologists, oncology nurses, nurse practitioners, physician assistants, primary care physicians, pulmonologists, and others involved and/or interested in the therapeutic management of patients with lung cancer.
Educational material updated... November 3, 2016.
Expiration of CME credit...May 3, 2017.
Financial Support...Merck.
After viewing Lung Immunotherapies: Shifting the Lung Cancer Treatment Paradigm, you will be better able to:
• Summarize the underlying principles for immunotherapeutic strategies taking into consideration lung cancer pathophysiology.
• Evaluate the safety and efficacy of available and emerging immunotherapies
• Determine if or when immunotherapy is appropriate in the first- and second-line settings for patients with metastatic NSCLC
• Address adverse events associated with immunotherapy in lung cancer

HER2+ BRCA INSTANT SYMPOSIUM: Updates on HER2 Positive Breast Cancer Management Free Breast Cancer CME
Live online June 10, 2016, and available on demand through June 10, 2017.
Posted by...Bernard Sklar, MD.
Free Breast Cancer CME Credit hours...1.0.
CME Credits Awarded by....Albert Einstein College of Medicine.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for oncologists, hematologist-oncologists, radiation oncologists, breast surgeons, oncology nurse practitioners, pharmacists, and other healthcare professionals who treat patients with breast cancer.
Educational material updated...June 10, 2016.
Expiration of CME credit...June 10, 2017.
Financial Support...Genentech.
Updates on HER2 Positive Breast Cancer Management consists of a single lecture with discussion:
Updates on HER2 Positive Breast Cancer Management
At the conclusion of Updates on HER2 Positive Breast Cancer Management, you will be able to:
• Summarize the efficacy and safety of new and emerging treatment approaches for HER2 positive breast cancer in the neoadjuvant, adjuvant and metastatic settings
• Evaluate therapeutic challenges associated with HER2-targeted treatment, including resistance, toxicity and optimal duration of treatment

Alzheimer Disease (AD) and Its Complications: Best Practices, Emerging Therapies, and Barriers to Care Alzheimer's Disease CME
Posted by...Bernard Sklar, MD.
Alzheimer's Disease CME Credit hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture.
Target Audiences...Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.
Educational material updated...December 21, 2015.
Expiration of CME credit...December 21, 2017.
Financial Support...AVANIR.
Topics covered in Alzheimer Disease (AD) and Its Complications include:
Epidemiology of and risk factors for Alzheimer Disease (AD), Symptomatology and diagnosis of AD, Treatment in patients with AD, Complications and barriers to optimal care in patients with AD and many more.
After completing Alzheimer Disease (AD) and Its Complications, you will be able to:
• Describe what is presently known about the pathophysiology of AD and the challenges associated with diagnosis and treatment of AD.
• Evaluate a treatment plan for a specific patient based on degree of AD to optimize safety and efficacy, suggesting modifications for improvement.
• Identify the present treatment options currently available for management of AD and apply them to patient cases using evidence-based medicine.
• Describe emerging drug therapies in the treatment of AD.
• Describe barriers to care and suggest therapies for treating cognitive and behavioral complications secondary to AD
In order to get credit from ScientiaCME, you must first establish a username and password.